BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 25721677)

  • 21. Diagnostic testing and treatment choices in primary vitreoretinal lymphoma.
    Rajagopal R; Harbour JW
    Retina; 2011 Mar; 31(3):435-40. PubMed ID: 21336066
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical characteristics of 95 patients with ocular adnexal and uveal lymphoma: treatment outcomes in extranodal marginal zone subtype.
    Portell CA; Aronow ME; Rybicki LA; Macklis R; Singh AD; Sweetenham JW
    Clin Lymphoma Myeloma Leuk; 2014 Jun; 14(3):203-10. PubMed ID: 24417911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intraocular lymphomas. Natural history based on a clinicopathologic study of eight cases and review of the literature.
    Qualman SJ; Mendelsohn G; Mann RB; Green WR
    Cancer; 1983 Sep; 52(5):878-86. PubMed ID: 6347357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary central nervous system lymphoma - ocular variant: an interdisciplinary review on management.
    Raval V; Binkley E; Aronow ME; Valenzuela J; Peereboom DM; Singh AD
    Surv Ophthalmol; 2021; 66(6):1009-1020. PubMed ID: 33762182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary CNS lymphoma.
    Touitou V; LeHoang P; Bodaghi B
    Curr Opin Ophthalmol; 2015 Nov; 26(6):526-33. PubMed ID: 26367092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is central nervous system prophylaxis necessary in ocular adnexal lymphoma?
    Restrepo A; Raez LE; Byrne GE; Johnson T; Ossi P; Benedetto P; Hamilton K; Whitcomb CC; Cassileth PA
    Crit Rev Oncog; 1998; 9(3-4):269-73. PubMed ID: 10201631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system manifestations of marginal zone B-cell lymphoma.
    Bayraktar S; Stefanovic A; Montague N; Davis J; Murray T; Lossos IS
    Ann Hematol; 2010 Oct; 89(10):1003-9. PubMed ID: 20440502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary intraocular lymphoma].
    Coupland SE; Heimann H
    Ophthalmologe; 2004 Jan; 101(1):87-98. PubMed ID: 14986704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lymphoma of the eye and its adnexa : Modern pathological diagnostics and systemic treatment].
    Fend F; Bonzheim I; Kakkassery V; Heindl LM; Illerhaus G
    Ophthalmologie; 2022 Jul; 119(7):664-674. PubMed ID: 35925409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eye involvement in primary central nervous system lymphoma.
    Farrall AL; Smith JR
    Surv Ophthalmol; 2020; 65(5):548-561. PubMed ID: 32057762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis and management of primary CNS lymphoma.
    Roth P; Korfel A; Martus P; Weller M
    Expert Rev Anticancer Ther; 2012 May; 12(5):623-33. PubMed ID: 22594897
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ocular manifestations and treatment of central nervous system lymphomas.
    Gündüz K; Pulido JS; McCannel CA; O'Neill BP
    Neurosurg Focus; 2006 Nov; 21(5):E9. PubMed ID: 17134125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Vitreoretinal Lymphoma: Management of Isolated Ocular Disease.
    Witmer MT
    Cancer Control; 2016 Apr; 23(2):110-6. PubMed ID: 27218787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Central Nervous System Lymphomas of the Brain: A Retrospective Analysis in a Single Institution.
    Lin TK; Yeh TH; Hsu PW; Chuang CC; Tu PH; Chen PY; Jung SM; Wei KC; Huang YC
    World Neurosurg; 2017 Jul; 103():550-556. PubMed ID: 28363832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Primary intraocular lymphoma invaded to the central nervous system after successful treatment with intraocular methotrexate injection].
    Watanabe K; Arai A; Takase H; Takahashi H; Iwanaga Y; Sugamoto Y; Sugita S; Mochizuki M; Miura O
    Rinsho Ketsueki; 2009 Mar; 50(3):182-6. PubMed ID: 19352085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Lymphoma of the ocular adnexa].
    Kakkassery V; Stübiger N; Adamietz IA; Tischoff I; Baraniskin A; Wunderlich IM
    Ophthalmologe; 2015 Mar; 112(3):210-6. PubMed ID: 25693875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. International Central Nervous System and Ocular Lymphoma Workshop: recommendations for the future.
    Nussenblatt RB; Chan CC; Wilson WH; Hochman J; Gottesman M;
    Ocul Immunol Inflamm; 2006 Jun; 14(3):139-44. PubMed ID: 16827214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vitreoretinal lymphoma: changing trends in diagnosis and local treatment modalities at a single institution.
    Turaka K; Bryan JS; De Souza S; Gordon AJ; Kwong HM; Ziemianski MC; Reddy R; Sell CH
    Clin Lymphoma Myeloma Leuk; 2012 Dec; 12(6):412-7. PubMed ID: 22995952
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Diagnosis and Treatment of Primary CNS Lymphoma.
    von Baumgarten L; Illerhaus G; Korfel A; Schlegel U; Deckert M; Dreyling M
    Dtsch Arztebl Int; 2018 Jun; 115(25):419-426. PubMed ID: 29999484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.